Intrinsic Therapeutics Revenue and Competitors

Boston, MA USA

Location

$236.4M

Total Funding

Estimated Revenue & Valuation

  • Intrinsic Therapeutics's estimated annual revenue is currently $12.9M per year.(i)
  • Intrinsic Therapeutics's estimated revenue per employee is $150,227
  • Intrinsic Therapeutics's total funding is $236.4M.

Employee Data

  • Intrinsic Therapeutics has 86 Employees.(i)
  • Intrinsic Therapeutics grew their employee count by 39% last year.

Intrinsic Therapeutics's People

NameTitleEmail/Phone
1
Area VP SalesReveal Email/Phone
2
Area VPReveal Email/Phone
3
Area VPReveal Email/Phone
4
COOReveal Email/Phone
5
Area VP, SalesReveal Email/Phone
6
Area VP Sales - TexasReveal Email/Phone
7
VP Global MarketingReveal Email/Phone
8
VP Customer Relations & Sales OperationsReveal Email/Phone
9
VP MarketingReveal Email/Phone
10
VP Health EconomicsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.1M1330%N/AN/A
#2
$14.3M599%N/AN/A
#3
$7.6M350%N/AN/A
#4
$28.9M1077%N/AN/A
#5
$0.1M10%N/AN/A
#6
$133.3M395-3%N/AN/A
#7
$30M111-12%N/AN/A
#8
$5.3M28-3%N/AN/A
#9
$5.3M284%N/AN/A
#10
$5.3M280%N/AN/A
Add Company

What Is Intrinsic Therapeutics?

Intrinsic Therapeutics, Inc., formerly Intrinsic Orthopedics, Inc., based in Wilmington, MA, is a medical device company focused on developing innovative therapies that address the spine market's many unmet clinical needs. The company's first product is a revolutionary spinal implant that is being developed to treat the most common causes of sciatica and low back pain.

keywords:Healthcare

$236.4M

Total Funding

86

Number of Employees

$12.9M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Intrinsic Therapeutics News

2022-04-19 - Exploring oncolytic viral therapeutics and immunotherapies derived from DNA and RNA

Furthermore, due to its intrinsic neurotropic property, ... Viral therapeutics based on DNA and RNA have distinct structural properties that...

2022-04-13 - Moving the Translational Needle in Breast Cancer ...

... Intrinsic LifeSciences (I), Silarus Therapeutics (I), Teva, Novartis, Merck, ... Research Funding: Blue Note Therapeutics (Inst).

2019-04-11 - Intrinsic Therapeutics Completes $52M Financing

Intrinsic Therapeutics, Inc., a Boston, MA-based medical device company focusing on surgeries to treat leg and low back pain resulting from ruptured lumbar discs with large anular defects, raised $52m in growth equity financing. The round was led by Questa Capital, with participation from exist ...

2019-04-11 - Intrinsic Therapeutics Completes $52M Financing

Intrinsic Therapeutics, Inc., a medical device company focusing on surgeries to treat leg and low back pain resulting from ruptured lumbar discs with large anular defects, today announced a $52m Series Growth equity financing. Questa Capital led the round, with participation from existing invest ...

2017-05-10 - Intrinsic Therapeutics Completes $49M Financing, Co-led by NEA and Delos Capital

Intrinsic Therapeutics, Inc. a medical device company that has developed a product to improve outcomes in lumbar discectomy patients, announced today that it recently closed a $49 million round of financing. The financing included a $28 million equity round co-led by New Enterprise Associates (N ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.1M868%N/A
#2
$12.5M86N/AN/A
#3
$12.8M88-9%N/A
#4
$12.9M89N/AN/A
#5
$19.8M90-8%N/A